MGI Tech Singapore Pte. Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in life sciences, and the Department of Pharmacy and Pharmaceutical Sciences in the National University of Singapore's Faculty of Science ("NUS PPS") recently announced the collaboration on a multi-omics laboratory. As part of MGI's global DCS Lab initiative, this joint effort integrates MGI's cutting-edge genomic sequencing and multi-omics technologies into pharmaceutical education, research, and drug discovery.

The facility marks a significant milestone in MGI's mission to empower researchers with high-precision analytical tools to bridge the gap between fundamental biology to frontier life science investigations.

A Comprehensive Multi-Omics Ecosystem

Under this collaboration, MGI will support NUS PPS in establishing a high-performance multi-omics environment. The lab features an integrated instrument portfolio designed to provide deep insights across DNA genomics, cell omics, and spatial omics. This suite of technology offers a streamlined and efficient workflow, enabling NUS PPS researchers to execute complex assignments across various omics layers for applications in precision medicine, drug discovery, and pharmaceutical sciences. The lab is positioned to become a critical incubator for pharmaceutical innovation, ultimately benefiting the broader healthcare ecosystem through enhanced drug discovery capabilities.

Dr. Liu Xin, Vice President of MGI, stated: "We are honored to partner with NUS Pharmacy and Pharmaceutical Sciences, a world-class department pushing the boundaries of pharmaceutical science. By providing cutting-edge technology platforms—from genomics to multi-omics—we are equipping tomorrow's pharmacists and researchers with the tools to drive discovery. We expect this multi-omics laboratory to become a catalyst for breakthrough science, demonstrating that the synergy between advanced technology and academic excellence is the key to unlocking the future of precision medicine."

Professor Giorgia Pastorin, Head of Department at NUS PPS, said: "We are proud to embark on this meaningful partnership that unites our shared commitment to scientific excellence and innovation. Together, we look forward to advancing discoveries that shape the future of healthcare and elevate the impact of translational research. We envision this collaboration as a catalyst for breakthroughs for real-world applications."